227 related articles for article (PubMed ID: 35877230)
1. Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists.
Druce I; Tawagi K; Shaw JLV; Ibrahim A; Lochnan H; Ong M
Curr Oncol; 2022 Jul; 29(7):4665-4677. PubMed ID: 35877230
[TBL] [Abstract][Full Text] [Related]
2. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Thapi S; Leiter A; Galsky M; Gallagher EJ
J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
[TBL] [Abstract][Full Text] [Related]
3. Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis.
Bando H; Yamamoto M; Urai S; Motomura Y; Sasaki Y; Ohmachi Y; Kobatake M; Tsujimoto Y; Oi-Yo Y; Suzuki M; Yamamoto N; Takahashi M; Fukuoka H; Iguchi G; Ogawa W
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418395
[TBL] [Abstract][Full Text] [Related]
4. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor-mediated hypophysitis: no place like home.
Cooksley T; Knight T; Lindsay D; Gupta A; Ho JH; Higham C; Lorigan P; Adam S
Clin Med (Lond); 2023 Jan; 23(1):81-84. PubMed ID: 36697002
[TBL] [Abstract][Full Text] [Related]
6. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T
Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115
[TBL] [Abstract][Full Text] [Related]
7. Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors.
Heck A; Winge-Main AK
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34045201
[TBL] [Abstract][Full Text] [Related]
8. The role of morning basal serum cortisol in assessment of hypothalamic pituitary-adrenal axis.
Yip CE; Stewart SA; Imran F; Clarke DB; Mokashi A; Kaiser SM; Imran SA
Clin Invest Med; 2013 Aug; 36(4):E216-22. PubMed ID: 23906493
[TBL] [Abstract][Full Text] [Related]
9. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
Johnson J; Goldner W; Abdallah D; Qiu F; Ganti AK; Kotwal A
J Natl Compr Canc Netw; 2023 Feb; 21(3):281-287. PubMed ID: 36828029
[TBL] [Abstract][Full Text] [Related]
10. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency.
Lee MT; Won JG; Lee TI; Yang HJ; Lin HD; Tang KT
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):580-7. PubMed ID: 12636203
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
[TBL] [Abstract][Full Text] [Related]
12. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
[TBL] [Abstract][Full Text] [Related]
13. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
[TBL] [Abstract][Full Text] [Related]
14. Corticotropic insufficiency in a monocentric prospective cohort of patients with lung cancer treated with nivolumab: Prevalence and etiology.
Ducloux R; Tavernier JY; Wojewoda P; Toullet F; Romanet S; Averous V
Ann Endocrinol (Paris); 2021 Feb; 82(1):8-14. PubMed ID: 33290748
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
[TBL] [Abstract][Full Text] [Related]
16. A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors.
Yeung SJ; Qdaisat A; Bischof JJ; Caterino JM; Kyriacou DN; Coyne Md C
Am J Emerg Med; 2024 Jun; 80():227.e1-227.e5. PubMed ID: 38705758
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.
Nguyen H; Shah K; Waguespack SG; Hu MI; Habra MA; Cabanillas ME; Busaidy NL; Bassett R; Zhou S; Iyer PC; Simmons G; Kaya D; Pitteloud M; Subudhi SK; Diab A; Dadu R
Endocr Relat Cancer; 2021 Jun; 28(7):419-431. PubMed ID: 33890870
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
Kanie K; Iguchi G; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Ogawa W; Takahashi Y
Cancer Immunol Immunother; 2021 Dec; 70(12):3669-3677. PubMed ID: 33977343
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitor-induced hypophysitis with transient ACTH-dependent hypercortisolism.
AlRubaish FA; Gupta N; Shi MZ; Christopoulos S
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38772867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
